UK Cancer Detection Firm CanSense Raises £1.5M for Development of Colorectal Cancer Test (360Dx) 0 By Praveen Suthrum on March 13, 2023 Exponential Tech Share Facebook Twitter LinkedIn Pinterest Email CanSense’s test is a blood-based assay that uses laser spectroscopy and artificial intelligence to identify early-stage colorectal cancer and precancerous polyps. Read More Artificial Intelligence Colorectal Cancer
50-Patient First-in-Human Study of Triton Robotic Endoscopy System From Neptune Medical Demonstrates No Adverse Events and 100% Cecal Intubation in Colonoscopy (Business Wire)
ECU Health performs North Carolina’s first single port colorectal robotic surgeries using the da Vinci SP system (ECU Health)